To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF83TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
390 supporting clones for gene ZNF83 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_018300.3   .a 1 to 2599 1 to 2599 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2599/2599
(100 %)
0 diff
(100 %id)
NM_001105549.1   .b 1 to 2940 1 to 2940 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2940/2940
(100 %)
0 diff
(100 %id)
DA880226 Prostate .b 30 to 594 2 to 566   tiling clone, capped   565/565
(100 %)
4 diff
(99.3 %id)
BX641726   .b 41 to 617 1 to 577   tiling clone,   577/577
(100 %)
1 diff
(99.9 %id)
BX647540 human retina .c 1 to 4440 1 to 4444 S96N H392L tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4444/4445
(99 %)
43 diff
(99.1 %id)
DB161658 thymus .c 1172 to 1701 2 to 532   tiling clone, capped   531/531
(100 %)
13 diff
(97.6 %id)
CV337417 epid_tumor .c 1592 to 2017 426 to 1   tiling clone, Submitted on the opposite strand 426/426
(100 %)
9 diff
(97.9 %id)
DB346897 thymus .c 3999 to 4441 444 to 1   tiling clone,   444/444
(100 %)
2 diff
(99.6 %id)
AK027518   .d 1 to 2633 1 to 2633 S96N R168C S246T S443P tiling clone, available from FLJ,   2633/2633
(100 %)
10 diff
(99.7 %id)
DA731895   .d 2 to 729 2 to 730   capped   729/730
(99 %)
11 diff
(98.5 %id)
CV315066 head_neck .e 1 to 179 186 to 8   tiling clone, Submitted on the opposite strand 179/192
(93 %)
0 diff
(100 %id)
AI393629 pooled .e 89 to 430 359 to 18   tiling clone,   342/359
(95 %)
0 diff
(100 %id)
DB287236 uterus .e 105 to 654 2 to 551   tiling clone, capped   550/550
(100 %)
17 diff
(97.0 %id)
T20199   .e 167 to 323 1 to 160   tiling clone,   160/160
(100 %)
8 diff
(95.0 %id)
DA857777 placenta .e 407 to 955 2 to 555   tiling clone, capped   554/554
(100 %)
17 diff
(97.0 %id)
DA098819 cerebellum .e 409 to 900 2 to 494   capped   493/493
(100 %)
23 diff
(95.4 %id)
DA092177 cerebellum .e 410 to 1002 2 to 594   tiling clone, capped   593/593
(100 %)
25 diff
(95.8 %id)
BX497663 Liver .e 412 to 1020 25 to 634   tiling clone,   610/634
(96 %)
6 diff
(99.1 %id)
DB135581 thymus .e 422 to 995 2 to 575   tiling clone, capped   574/574
(100 %)
13 diff
(97.8 %id)
DA097814 cerebellum .e 432 to 991 2 to 562   capped   561/561
(100 %)
23 diff
(96.0 %id)
DB158402 thymus .e 478 to 1078 2 to 602   capped   601/601
(100 %)
14 diff
(97.7 %id)
DA510678 brain .e 567 to 1092 2 to 527   tiling clone, capped   526/526
(100 %)
12 diff
(97.8 %id)
DA402717 thalamus .e 595 to 1069 2 to 476   capped   475/475
(100 %)
10 diff
(97.9 %id)
DA013823 adrenal gland .e 601 to 1092 2 to 488   capped   487/487
(100 %)
11 diff
(97.8 %id)
DA860765 placenta .e 601 to 1139 2 to 540   tiling clone, capped   539/539
(100 %)
6 diff
(98.9 %id)
CN279097 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 711 to 991 1 to 281       281/281
(100 %)
2 diff
(99.3 %id)
AL697857 human skeletal muscle .e 738 to 1560 1 to 820       820/820
(100 %)
8 diff
(99.1 %id)
CN279096 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 744 to 1396 1 to 651       651/651
(100 %)
5 diff
(99.3 %id)
AK055318 brain .e 746 to 3870 1 to 3120 S96N Y401S tiling clone, available from FLJ,   3120/3120
(100 %)
9 diff
(99.8 %id)
DA073504 cerebellum .e 746 to 1306 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
DA513229 brain .e 747 to 1303 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
CN279098 embryonic stem cells, cell lines H1, H7, andH9 .e 777 to 1375 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
AA021149 eye, retina .e 779 to 1231 1 to 460       460/462
(99 %)
7 diff
(98.5 %id)
DA876306 Prostate .e 1054 to 1618 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA352176 substantia nigra .e 1102 to 1658 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA016890 adrenal gland .e 1121 to 1425 2 to 306   capped   305/305
(100 %)
1 diff
(99.7 %id)
DA847417 placenta .e 1204 to 1768 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
AL692068   .e 1219 to 1815 9 to 605   tiling clone,   597/597
(100 %)
1 diff
(99.9 %id)
DB186233 liver, tumor tissue .e 1293 to 1881 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA632517 Kidney .e 1297 to 1870 2 to 575   capped   574/575
(99 %)
4 diff
(99.4 %id)
BP345593 synovial membrane .e 1318 to 1899 1 to 581   tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
DB316582 brain .e 3321 to 3870 550 to 1       550/550
(100 %)
3 diff
(99.5 %id)
AA021150 eye, retina .e 3464 to 3870 407 to 1       407/411
(99 %)
1 diff
(99.8 %id)
DB352846 uterus .e 3522 to 3881 361 to 1   tiling clone,   361/361
(100 %)
2 diff
(99.5 %id)
AK289399   .f 1 to 2588 2 to 2589 S96N tiling clone,   2589/2589
(100 %)
7 diff
(99.8 %id)
DA023799   .f 1 to 584 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
DA568503 whole embryo, mainly head .f 1187 to 1940 2 to 756   capped   755/757
(99 %)
7 diff
(99.1 %id)
AI017196 pooled .f 2280 to 2598 321 to 3       319/321
(99 %)
0 diff
(100 %id)
DB355015 whole embryo, mainly head .f 2369 to 2938 568 to 1   tiling clone,   568/589
(96 %)
14 diff
(97.7 %id)
AI446670 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 2577 to 2949 373 to 1   tiling clone,   373/375
(99 %)
4 diff
(99.0 %id)
AK075066 placenta .g 1 to 2803 4 to 2806 T70I S96N H139R N159H Q160N ... tiling clone, available from FLJ,   2806/2806
(100 %)
67 diff
(97.7 %id)
CV340325 colon .g 1130 to 1353 21 to 243   tiling clone,   223/243
(91 %)
6 diff
(97.6 %id)
BF345717 anaplastic oligodendroglioma with 1p/19qloss, brain .g 1141 to 1882 11 to 751       741/1001
(74 %)
17 diff
(98.4 %id)
CN426877 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1180 to 1842 9 to 671       663/671
(98 %)
6 diff
(99.2 %id)
CB963288 Blood vessels - aorta, basilar and artery .g 1186 to 1896 1 to 714       714/750
(95 %)
5 diff
(99.4 %id)
BP379163 uterus .g 1208 to 1766 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
CN426874 embryonic stem cells, DMSO-treated H9 cellline .g 1216 to 1960 10 to 756       747/756
(98 %)
6 diff
(99.3 %id)
BP367554 thymus .g 1224 to 1805 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BG429909 Kidney .g 1280 to 2052 1 to 767       767/801
(95 %)
13 diff
(98.4 %id)
DA833567 placenta .g 1289 to 2130 2 to 851   capped   850/850
(100 %)
54 diff
(93.7 %id)
CB215136 normal endometrium, late proliferativephase, cycle day 13, uterus .g 1301 to 1874 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
BG573515 placenta .g 1302 to 1962 1 to 666       666/666
(100 %)
7 diff
(99.0 %id)
CD629206   .g 1306 to 1833 8 to 535       528/535
(98 %)
11 diff
(98.0 %id)
CD629207   .g 1306 to 1839 534 to 1       534/541
(98 %)
6 diff
(98.9 %id)
BX509513   .g 1324 to 2016 1 to 694   tiling clone,   694/694
(100 %)
1 diff
(99.9 %id)
BG741860 skin .g 1339 to 2063 1 to 726       726/726
(100 %)
3 diff
(99.6 %id)
AA361877   .g 1344 to 1540 1 to 197       197/197
(100 %)
0 diff
(100 %id)
AY500361   .g 1418 to 2781 2 to 1364   tiling clone,   1363/1365
(99 %)
14 diff
(99.0 %id)
AA029009 uterus .g 1474 to 1570 1 to 97       97/97
(100 %)
0 diff
(100 %id)
AA028917 uterus .g 1961 to 2209 249 to 1       249/253
(98 %)
1 diff
(99.7 %id)
AU158190 placenta .g 2225 to 2803 575 to 1   tiling clone,   575/575
(100 %)
17 diff
(97.1 %id)
NM_001105554.1   .h 1 to 2515 1 to 2515 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2515/2515
(100 %)
0 diff
(100 %id)
AA336851 endometrium .h 37 to 332 1 to 297   tiling clone,   297/297
(100 %)
1 diff
(99.7 %id)
DR761375 embryonic stem .h 62 to 833 1 to 771   tiling clone,   773/771
(100 %)
4 diff
(99.5 %id)
AK027782 placenta .h 136 to 2113 1 to 1978 S96N H447R tiling clone, available from FLJ,   1978/1978
(100 %)
5 diff
(99.8 %id)
DA829333 placenta .h 137 to 891 2 to 757   capped   756/756
(100 %)
6 diff
(99.3 %id)
AU156259 placenta .h 1712 to 2102 406 to 12       395/413
(95 %)
0 diff
(100 %id)
NM_001105553.1   .i 1 to 2878 1 to 2878 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2878/2878
(100 %)
0 diff
(100 %id)
BC032867 Brain, hippocampus .i 40 to 2878 1 to 2839 S96N tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2839/2839
(100 %)
14 diff
(99.6 %id)
BI551409 brain, hippocampus .i 40 to 711 1 to 671       671/671
(100 %)
10 diff
(98.6 %id)
TI_44169864   .i 42 to 711 85 to 753       669/753
(88 %)
14 diff
(98.2 %id)
CN417587 embryonic stem cells, cell lines H1, H7, andH9 .i 56 to 275 10 to 229       220/229
(96 %)
6 diff
(97.4 %id)
CN426879 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 434 to 1144 1 to 711       711/711
(100 %)
2 diff
(99.8 %id)
AA332080 Embryo, 8 weeks .i 473 to 752 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
BM477047 lymph, lymphoma, cell line .i 476 to 1545 1 to 1078       1078/1116
(96 %)
49 diff
(95.7 %id)
AV726837 hypothalamus .i 479 to 1181 1 to 701       701/701
(100 %)
7 diff
(99.1 %id)
NR_003936.1   .j 1 to 2961 2 to 2962 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2962/2962
(100 %)
0 diff
(100 %id)
DA111455 cerebellum .j 53 to 400 2 to 352   capped   351/363
(96 %)
5 diff
(98.7 %id)
DB095489 testis .j 75 to 616 2 to 542   capped   541/545
(99 %)
5 diff
(99.1 %id)
DA795304 brain .j 91 to 642 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
DA924899 small intestine .j 142 to 722 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA828340 placenta .j 146 to 891 2 to 754   capped   753/757
(99 %)
11 diff
(98.6 %id)
DA397058 thalamus .j 147 to 732 2 to 588   capped   587/587
(100 %)
3 diff
(99.5 %id)
DA684911   .j 147 to 696 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
DB254966 uterus .j 147 to 723 2 to 580   capped   579/579
(100 %)
7 diff
(98.8 %id)
AV764447 bone marrow .j 149 to 615 1 to 467       467/676
(69 %)
12 diff
(98.3 %id)
CD629208   .j 621 to 1365 1 to 743       743/743
(100 %)
4 diff
(99.5 %id)
BE673902 carcinoid, lung .j 624 to 903 1 to 280     Submitted on the opposite strand 280/280
(100 %)
2 diff
(99.3 %id)
AW937419 denis_drash .j 652 to 1148 42 to 541       500/541
(92 %)
6 diff
(98.9 %id)
DA157241 amygdala .j 656 to 1224 2 to 572   capped   571/571
(100 %)
5 diff
(99.2 %id)
DB207598 trachea .j 657 to 1195 2 to 541   capped   540/540
(100 %)
4 diff
(99.3 %id)
DA576007   .j 689 to 1260 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
AU132197   .j 693 to 1528 2 to 844   capped Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 843/866
(97 %)
13 diff
(98.5 %id)
BE843977 testis_normal .j 694 to 952 258 to 1       258/258
(100 %)
2 diff
(99.3 %id)
BP274886 Kidney .j 696 to 1279 1 to 583       583/583
(100 %)
6 diff
(99.0 %id)
BQ884275 sciatic nerve .j 707 to 1577 1 to 883       883/904
(97 %)
24 diff
(97.4 %id)
BP281027   .j 728 to 1150 1 to 423       423/427
(99 %)
4 diff
(99.1 %id)
DA380756 thalamus .j 739 to 1308 2 to 571   capped   570/571
(99 %)
1 diff
(99.9 %id)
AK001877 placenta .j 747 to 2950 1 to 2204 T70I S96N available from FLJ,   2204/2204
(100 %)
7 diff
(99.7 %id)
AU135985 placenta .j 748 to 1581 2 to 837   capped   836/836
(100 %)
14 diff
(98.4 %id)
BQ894811 Spleen .j 751 to 1660 23 to 941       919/942
(97 %)
24 diff
(97.5 %id)
AW662754 pooled .j 766 to 1262 497 to 1       497/497
(100 %)
0 diff
(100 %id)
DA375932 thalamus .j 796 to 1363 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
BF348897 denis_drash .j 819 to 1152 1 to 333       333/333
(100 %)
2 diff
(99.4 %id)
AW630944 2 pooled high-grade transitional celltumors, genitourinary tract .j 823 to 1296 1 to 474       474/475
(99 %)
3 diff
(99.4 %id)
DR762135 embryonic stem .j 825 to 1625 1 to 801       801/801
(100 %)
5 diff
(99.4 %id)
AI243449 pooled .j 827 to 1262 436 to 1       436/436
(100 %)
0 diff
(100 %id)
BP379922 uterus .j 828 to 1403 1 to 578       578/578
(100 %)
5 diff
(99.2 %id)
BE706930 head_neck .j 829 to 1179 373 to 23       351/373
(94 %)
0 diff
(100 %id)
AI288925 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 829 to 1240 413 to 1       413/413
(100 %)
3 diff
(99.3 %id)
EL734831 mixed .j 848 to 1502 1 to 651       651/705
(92 %)
9 diff
(98.8 %id)
DA830246 placenta .j 853 to 1563 2 to 714   capped   713/801
(89 %)
7 diff
(99.2 %id)
AU138727 placenta .j 857 to 1652 2 to 803   capped   802/805
(99 %)
16 diff
(98.1 %id)
BP291200 lung .j 864 to 1444 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
DA940990 Spleen .j 874 to 1459 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BP292038 lung .j 879 to 1458 1 to 583       583/583
(100 %)
18 diff
(97.0 %id)
AI219729 pooled .j 944 to 1375 434 to 3       432/434
(99 %)
0 diff
(100 %id)
DA377634 thalamus .j 959 to 1489 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA041923 bladder .j 963 to 1537 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BG500535 adenocarcinoma, Prostate .j 968 to 1651 1 to 691       691/691
(100 %)
16 diff
(97.7 %id)
DA253137 caudate nucleus .j 985 to 1572 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA383755 thalamus .j 988 to 1614 2 to 630   capped   629/629
(100 %)
2 diff
(99.7 %id)
DA369575 subthalamic nucleus .j 1058 to 1625 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA252847 caudate nucleus .j 1064 to 1645 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA380505 thalamus .j 1069 to 1619 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
DA687241   .j 1096 to 1641 2 to 548   capped   547/548
(99 %)
5 diff
(99.1 %id)
BX477880   .j 1097 to 1588 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BE178922 head_neck .j 1103 to 1254 149 to 1     Submitted on the opposite strand 149/149
(100 %)
6 diff
(96.0 %id)
AI203726 lung .j 1179 to 1375 198 to 2       197/198
(99 %)
0 diff
(100 %id)
AA166907   .j 1453 to 2000 1 to 539     Submitted on the opposite strand 539/556
(96 %)
15 diff
(97.4 %id)
DT215469 brain .j 1661 to 2373 1 to 712       712/712
(100 %)
1 diff
(99.9 %id)
BP228460   .j 1669 to 2247 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BE832329 marrow .j 1677 to 2049 12 to 385       374/385
(97 %)
6 diff
(98.5 %id)
BE163010 head_neck .j 1688 to 1870 198 to 18     Submitted on the opposite strand 181/198
(91 %)
0 diff
(100 %id)
DR759934 embryonic stem .j 1698 to 2497 1 to 800       800/800
(100 %)
0 diff
(100 %id)
DA571788 whole embryo, mainly head .j 1707 to 2445 2 to 735   fully sequenced, capped   734/734
(100 %)
7 diff
(99.1 %id)
CB242588 Human Lung Epithelial cells, lung .j 1707 to 2349 665 to 24   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 642/646
(99 %)
2 diff
(99.7 %id)
AW966597   .j 1776 to 2293 42 to 562       521/563
(92 %)
19 diff
(96.7 %id)
AA384988 thyroid gland .j 1780 to 1972 1 to 193       193/193
(100 %)
1 diff
(99.5 %id)
EL955355 eyeball .j 1786 to 2267 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
AA167094   .j 1805 to 2380 573 to 1     Submitted on the opposite strand 573/600
(95 %)
11 diff
(98.2 %id)
AV755425 bone marrow .j 1827 to 2273 72 to 509       438/510
(85 %)
5 diff
(99.1 %id)
AA993239   .j 1915 to 2349 466 to 32   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 435/435
(100 %)
0 diff
(100 %id)
CD356370 Blood vessels - aorta, basilar and artery .j 1933 to 2661 1 to 739       739/740
(99 %)
25 diff
(96.7 %id)
BM838760 Ascites, stomach .j 1933 to 2273 1 to 343       343/343
(100 %)
3 diff
(99.2 %id)
AA433979.
matches multiple genes
ovarian tumor, ovary .j 1952 to 2376 15 to 439     also hits gene TNFRSF14 425/439
(96 %)
6 diff
(98.7 %id)
AA093883   .j 1956 to 2133 1 to 177       177/184
(96 %)
3 diff
(98.4 %id)
BF793520 adrenal cortex carcinoma, cell line, adrenal gland .j 1995 to 2766 1 to 785       785/868
(90 %)
24 diff
(97.3 %id)
AA029756 uterus .j 1996 to 2416 1 to 422       422/422
(100 %)
1 diff
(99.8 %id)
CN426875 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 2019 to 2238 1 to 220       220/220
(100 %)
1 diff
(99.6 %id)
AI183313 placenta .j 2044 to 2398 356 to 2       355/356
(99 %)
0 diff
(100 %id)
N51151 multiple sclerosis lesions .j 2095 to 2506 1 to 412   fully sequenced,   412/412
(100 %)
8 diff
(98.1 %id)
BG260506 bladder, transitional cell papilloma, cell line .j 2106 to 2829 1 to 721       721/941
(76 %)
12 diff
(98.8 %id)
AA602187   .j 2134 to 2497 8 to 372       365/372
(98 %)
6 diff
(98.4 %id)
AW801248 uterus .j 2136 to 2693 558 to 1       558/558
(100 %)
7 diff
(98.8 %id)
BI007340 kidney_tumor .j 2141 to 2240 16 to 115       100/119
(84 %)
1 diff
(99.2 %id)
H88995 cochlea, ear .j 2165 to 2514 1 to 358       358/360
(99 %)
8 diff
(97.8 %id)
BE767608 placenta_normal .j 2187 to 2451 278 to 14       265/307
(86 %)
0 diff
(100 %id)
BE165647 head_neck .j 2195 to 2624 430 to 1     Submitted on the opposite strand 430/430
(100 %)
5 diff
(98.9 %id)
BE938810 testis_normal .j 2200 to 2451 262 to 18       245/262
(93 %)
0 diff
(100 %id)
BE938818 testis_normal .j 2200 to 2444 246 to 1       246/246
(100 %)
5 diff
(98.0 %id)
BE938819 testis_normal .j 2200 to 2444 1 to 245       245/245
(100 %)
1 diff
(99.6 %id)
BE938821 testis_normal .j 2200 to 2444 1 to 245       245/245
(100 %)
1 diff
(99.6 %id)
FN098902 breast carcinoma .j 2201 to 2273 1 to 73       73/73
(100 %)
3 diff
(95.9 %id)
BM833201 stomach .j 2201 to 2465 1 to 265       265/265
(100 %)
8 diff
(97.0 %id)
BM829710 stomach .j 2229 to 2727 1 to 500       500/500
(100 %)
22 diff
(95.6 %id)
TI_149283528   .j 2238 to 2950 793 to 81   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 713/714
(99 %)
4 diff
(99.5 %id)
BU680181 lung, Primary Lung Epithelial Cells .j 2258 to 2950 711 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 693/693
(100 %)
2 diff
(99.8 %id)
CN426878 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 2266 to 2520 262 to 8     Submitted on the opposite strand 255/262
(97 %)
0 diff
(100 %id)
H03766 placenta .j 2268 to 2587 1 to 320   fully sequenced,   320/320
(100 %)
1 diff
(99.7 %id)
AA043742 uterus .j 2269 to 2536 4 to 275   fully sequenced,   272/275
(98 %)
9 diff
(96.8 %id)
FN048386 breast carcinoma .j 2275 to 2379 105 to 1     Submitted on the opposite strand 105/105
(100 %)
1 diff
(99.1 %id)
EC532304 Prostate .j 2279 to 2383 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
AW371991 breast .j 2289 to 2484 3 to 200       198/206
(96 %)
12 diff
(94.2 %id)
AW439565 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 2335 to 2951 620 to 4       617/620
(99 %)
0 diff
(100 %id)
FN050827 breast carcinoma .j 2337 to 2451 1 to 115       115/115
(100 %)
0 diff
(100 %id)
DB375330 placenta .j 2361 to 2950 587 to 1       587/594
(98 %)
17 diff
(97.2 %id)
AI890158 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 2377 to 2951 577 to 2       576/582
(98 %)
0 diff
(100 %id)
AI827530 pooled .j 2382 to 2951 570 to 1       570/570
(100 %)
3 diff
(99.5 %id)
DB369200   .j 2392 to 2950 573 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 560/560
(100 %)
12 diff
(97.9 %id)
AI887525 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 2393 to 2949 557 to 1       557/557
(100 %)
0 diff
(100 %id)
AI859703 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 2393 to 2950 557 to 1       557/557
(100 %)
5 diff
(99.2 %id)
AW118200 pooled .j 2396 to 2950 567 to 13   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 555/555
(100 %)
6 diff
(99.0 %id)
AU157723 placenta .j 2400 to 2951 551 to 3       549/579
(94 %)
0 diff
(100 %id)
DB358682 whole embryo, mainly head .j 2415 to 2950 536 to 1   fully sequenced,   536/536
(100 %)
9 diff
(98.4 %id)
BE927508 colon .j 2429 to 2753 326 to 4       323/328
(98 %)
0 diff
(100 %id)
BF335051 colon .j 2429 to 2738 311 to 3       309/313
(98 %)
0 diff
(100 %id)
BP392125 pancreatic islet .j 2450 to 2950 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
BP394337 pancreatic islet .j 2451 to 2950 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AA430563.
matches multiple genes
ovarian tumor, ovary .j 2457 to 2951 495 to 1     also hits gene UFC1 495/495
(100 %)
1 diff
(99.8 %id)
AA749212 germinal center B cell .j 2457 to 2910 454 to 1       454/454
(100 %)
0 diff
(100 %id)
AA883993 pooled .j 2463 to 2956 496 to 3       494/496
(99 %)
0 diff
(100 %id)
AA029288 uterus .j 2466 to 2950 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AI095763 uterus .j 2476 to 2950 475 to 1       475/475
(100 %)
0 diff
(100 %id)
FN105838 breast carcinoma .j 2478 to 2583 109 to 1     Submitted on the opposite strand 109/109
(100 %)
3 diff
(97.3 %id)
BP393389 pancreatic islet .j 2480 to 2950 1 to 472     Submitted on the opposite strand 472/472
(100 %)
3 diff
(99.4 %id)
AI598263 adenocarcinoma, Pancreas .j 2482 to 2951 472 to 3       470/472
(99 %)
0 diff
(100 %id)
AA369249 placenta .j 2485 to 2775 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
AW243702 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 2489 to 2950 462 to 1       462/463
(99 %)
5 diff
(99.0 %id)
AW662852 pooled .j 2490 to 2949 462 to 3       460/462
(99 %)
0 diff
(100 %id)
N47896 multiple sclerosis lesions .j 2491 to 2955 470 to 1   fully sequenced,   470/470
(100 %)
9 diff
(98.1 %id)
AI634574 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 2493 to 2950 471 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 458/458
(100 %)
1 diff
(99.8 %id)
AI079917   .j 2494 to 2951 460 to 3       458/460
(99 %)
0 diff
(100 %id)
AU156407 placenta .j 2495 to 2950 458 to 1       458/458
(100 %)
9 diff
(98.1 %id)
AA452390   .j 2501 to 2950 1 to 450       450/450
(100 %)
3 diff
(99.4 %id)
AI220990 placenta .j 2503 to 2950 449 to 1       449/449
(100 %)
8 diff
(98.3 %id)
AA043743 uterus .j 2506 to 2950 449 to 1   fully sequenced,   449/449
(100 %)
4 diff
(99.2 %id)
AA969116 pooled .j 2522 to 2956 437 to 4       434/438
(99 %)
0 diff
(100 %id)
AI610785 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 2522 to 2953 435 to 4       432/444
(97 %)
0 diff
(100 %id)
AI634584 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 2522 to 2950 442 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 429/438
(97 %)
0 diff
(100 %id)
AA621433   .j 2524 to 2951 430 to 4       427/430
(99 %)
0 diff
(100 %id)
AA888601 carcinoid, lung .j 2524 to 2923 400 to 1       400/400
(100 %)
3 diff
(99.3 %id)
AA971019 pooled .j 2524 to 2951 428 to 1       428/428
(100 %)
0 diff
(100 %id)
AI818902 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 2524 to 2950 448 to 21   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 428/428
(100 %)
6 diff
(98.6 %id)
AI926025 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 2524 to 2950 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AW780141 colon, moderately-differentiated adenocarcinoma .j 2524 to 2956 435 to 3       433/435
(99 %)
0 diff
(100 %id)
BE677662 dorsal root ganglia .j 2524 to 2951 428 to 1       428/428
(100 %)
0 diff
(100 %id)
BF436528 breast, invasive ductal carcinoma, 3 pooled samples .j 2524 to 2950 427 to 1       427/427
(100 %)
0 diff
(100 %id)
BX112357 adenocarcinoma, Pancreas .j 2526 to 2950 438 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 424/424
(100 %)
2 diff
(99.6 %id)
AI279436 carcinoid, lung .j 2527 to 2950 443 to 20   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
AW131171 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 2530 to 2950 421 to 1       421/421
(100 %)
0 diff
(100 %id)
CA444215 lung, Metastatic Chondrosarcoma .j 2535 to 2950 434 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 416/416
(100 %)
2 diff
(99.6 %id)
AI922025 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 2536 to 2951 416 to 1       416/416
(100 %)
2 diff
(99.6 %id)
AI300047 2 pooled tumors (clear cell type), Kidney .j 2539 to 2951 416 to 4       413/416
(99 %)
0 diff
(100 %id)
BQ028834 Bone, Subchondral Bone .j 2539 to 2954 434 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 416/416
(100 %)
1 diff
(99.8 %id)
AW627656 2 pooled high-grade transitional celltumors, genitourinary tract .j 2542 to 2950 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AI955368 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 2545 to 2602 58 to 1       58/58
(100 %)
1 diff
(98.3 %id)
BE161811 head_neck .j 2547 to 2686 1 to 138       138/144
(95 %)
4 diff
(97.3 %id)
AW769987 lymph node, lymphoma, follicular mixed small and largecell .j 2548 to 2950 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
AA579993 breast .j 2554 to 2950 397 to 1       397/397
(100 %)
0 diff
(100 %id)
H02869 placenta .j 2557 to 2948 393 to 4   fully sequenced,   390/393
(99 %)
5 diff
(98.8 %id)
AI469540 colon, moderately-differentiated adenocarcinoma .j 2557 to 2951 397 to 3       395/397
(99 %)
0 diff
(100 %id)
AA912768 pooled .j 2573 to 2951 382 to 4       379/382
(99 %)
0 diff
(100 %id)
AI926028 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 2590 to 2950 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AA937998 2 pooled tumors (clear cell type), Kidney .j 2594 to 2950 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
AA342184 Spleen .j 2616 to 2950 336 to 1       336/336
(100 %)
3 diff
(99.2 %id)
AA834867 ovary .j 2616 to 2943 347 to 20   AAA   328/335
(97 %)
0 diff
(100 %id)
AI873839 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 2634 to 2951 318 to 1       318/318
(100 %)
0 diff
(100 %id)
AA866089 Kidney, kidney tumor .j 2646 to 2954 333 to 25   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 309/309
(100 %)
2 diff
(99.4 %id)
BM700854 eye, human retina .j 2672 to 2950 1 to 279   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 279/279
(100 %)
2 diff
(99.3 %id)
AI926057 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 2679 to 2950 272 to 1       272/272
(100 %)
0 diff
(100 %id)
AA911119 carcinoid, lung .j 2704 to 2950 259 to 13   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 247/247
(100 %)
0 diff
(100 %id)
AW150449 serous papillary carcinoma, high grade, 2pooled tumors, uterus .j 2704 to 2956 258 to 3       256/258
(99 %)
0 diff
(100 %id)
H88778 cochlea, ear .j 2711 to 2932 222 to 1       222/222
(100 %)
0 diff
(100 %id)
AA621107   .j 2796 to 2956 162 to 2       161/162
(99 %)
0 diff
(100 %id)
BM672213 eye, human retina .j 2814 to 2919 106 to 1   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 106/106
(100 %)
0 diff
(100 %id)
EC448265 Prostate .j 2826 to 2928 1 to 103       103/107
(96 %)
7 diff
(93.5 %id)
EC528108 Prostate .j 2826 to 2930 1 to 105       105/105
(100 %)
0 diff
(100 %id)
FN074410 breast carcinoma .j 2846 to 2908 1 to 65       65/66
(98 %)
3 diff
(95.5 %id)
DA237809 brain .k 1 to 583 2 to 585   tiling clone, capped   584/584
(100 %)
3 diff
(99.5 %id)
DA626221 Kidney .k 20 to 569 2 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
DB238373 trachea .k 20 to 614 2 to 597   capped   596/596
(100 %)
3 diff
(99.5 %id)
DA067188 cerebellum .k 25 to 588 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
CN272026 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 72 to 659 20 to 608 R27K E181G K182E S183V I184Y ... tiling clone,   591/617
(95 %)
9 diff
(98.6 %id)
CN315256 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 1 to 451 15 to 464   tiling clone,   453/464
(97 %)
10 diff
(97.9 %id)
NM_001105552.1   .l 420 to 3145 1 to 2726   RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2726/2726
(100 %)
0 diff
(100 %id)
BP222374   .l 446 to 1028 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA279391 corpus callosum .l 447 to 1034 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
DA499102 brain .l 447 to 1013 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
DB020020 testis .l 447 to 1010 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB087114 testis .l 449 to 1013 2 to 567   capped   566/566
(100 %)
5 diff
(99.2 %id)
DB087116 testis .l 449 to 1014 2 to 567   capped   566/566
(100 %)
4 diff
(99.3 %id)
CD708888 normal nasopharynx .l 451 to 827 18 to 395       378/395
(95 %)
8 diff
(98.0 %id)
BP288250 lung .l 454 to 1035 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
DA592481 lung .l 455 to 1034 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
DA162889 amygdala .l 456 to 985 2 to 532   capped   531/531
(100 %)
4 diff
(99.3 %id)
DA390054 thalamus .l 456 to 1020 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA449506 tongue, tumor tissue .l 456 to 944 2 to 490   capped   489/489
(100 %)
0 diff
(100 %id)
DA509259 brain .l 456 to 1027 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA587074 lung .l 456 to 1016 2 to 563   capped   562/562
(100 %)
4 diff
(99.3 %id)
DA587474 lung .l 456 to 1032 2 to 578   capped   577/578
(99 %)
2 diff
(99.7 %id)
DA701638   .l 456 to 847 2 to 393   capped   392/392
(100 %)
1 diff
(99.8 %id)
DB022247 testis .l 456 to 1025 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB262877 uterus .l 456 to 994 2 to 540   capped   539/539
(100 %)
3 diff
(99.5 %id)
DA737787   .l 457 to 1276 2 to 831   capped   830/833
(99 %)
17 diff
(98.0 %id)
DB199147 trachea .l 457 to 1024 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA589607 lung .l 459 to 1026 11 to 578   capped   568/568
(100 %)
0 diff
(100 %id)
DB026114 testis .l 459 to 1021 8 to 570   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA347859 substantia nigra .l 462 to 1031 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA665808   .l 463 to 1010 2 to 549   capped   548/548
(100 %)
3 diff
(99.5 %id)
DA867504 Prostate .l 463 to 987 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
DA982705 synovial membrane tissue from rheumatioidarthritis .l 463 to 1036 2 to 575   capped   574/575
(99 %)
3 diff
(99.5 %id)
DT218243 brain .l 464 to 1022 1 to 558       558/558
(100 %)
4 diff
(99.3 %id)
DA505151 brain .l 464 to 1040 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA667224 esophagus .l 465 to 932 2 to 469   capped   468/470
(99 %)
4 diff
(99.2 %id)
DA902824   .l 465 to 1021 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA198154 brain .l 466 to 970 2 to 506   capped   505/505
(100 %)
1 diff
(99.9 %id)
DA258790 caudate nucleus .l 466 to 1034 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA282814 corpus callosum .l 466 to 1018 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
AA132592 colon, tumor .l 469 to 904 1 to 443       443/447
(99 %)
15 diff
(96.7 %id)
BQ440250 leiomyosarcoma, uterus .l 472 to 1284 1 to 826       826/891
(92 %)
20 diff
(97.8 %id)
CD101746 Human Placenta, placenta .l 473 to 1172 28 to 738       711/807
(88 %)
25 diff
(97.0 %id)
DA173284 amygdala .l 474 to 955 2 to 483   capped   482/484
(99 %)
5 diff
(99.0 %id)
DA516642 brain .l 475 to 1006 11 to 542   capped   532/532
(100 %)
4 diff
(99.3 %id)
DA474436   .l 476 to 1044 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
AK225945 Kidney .l 796 to 3130 1 to 2335   tiling clone,   2335/2335
(100 %)
5 diff
(99.8 %id)
BC050407 Peripheral Nervous System, sympathetictrunk .l 806 to 3134 1 to 2329   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2329/2329
(100 %)
4 diff
(99.9 %id)
TI_1948215561   .l 947 to 1875 1050 to 118       933/1312
(71 %)
0 diff
(100 %id)
TI_1948216035   .l 947 to 1869 129 to 1047       919/1307
(70 %)
22 diff
(98.4 %id)
TI_1948215720   .l 948 to 1875 1040 to 113       928/1343
(69 %)
0 diff
(100 %id)
CD629209   .l 950 to 1810 862 to 3       860/862
(99 %)
0 diff
(100 %id)
TI_1948215886   .l 959 to 1875 1048 to 119       930/1356
(68 %)
0 diff
(100 %id)
DB031610 testis .l 1146 to 1763 2 to 619   capped   618/618
(100 %)
2 diff
(99.7 %id)
BE175387 head_neck .l 1202 to 1825 7 to 630       624/630
(99 %)
6 diff
(99.1 %id)
M27877   .l 1213 to 3135 14 to 1935       1922/1945
(98 %)
9 diff
(99.6 %id)
BQ722616 sympathetic trunk .l 1238 to 2076 1 to 849       849/852
(99 %)
12 diff
(98.6 %id)
DA968703 stomach .l 1287 to 1829 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
BP379930 uterus .l 1291 to 1854 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
DB107467 thymus .l 1296 to 1854 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP370706 testis .l 1302 to 1863 1 to 564       564/570
(98 %)
23 diff
(96.0 %id)
R70961 placenta .l 1306 to 1789 1 to 486       486/486
(100 %)
9 diff
(98.2 %id)
DA141463 alzheimer cortex .l 1310 to 1878 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB026505 testis .l 1313 to 1876 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB346925 thymus .l 1356 to 1892 1 to 537     Submitted on the opposite strand 537/537
(100 %)
12 diff
(97.8 %id)
DA059092 cerebellum .l 1401 to 1948 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BI760646 pooled colon, kidney, stomach .l 1463 to 2236 1 to 776       776/851
(91 %)
7 diff
(99.2 %id)
TI_57147700   .l 1463 to 2335 87 to 957       871/957
(91 %)
13 diff
(98.7 %id)
BI760718 pooled colon, kidney, stomach .l 1464 to 2335 1 to 870       870/870
(100 %)
13 diff
(98.6 %id)
TI_57147777   .l 1464 to 2236 32 to 806       775/881
(87 %)
7 diff
(99.3 %id)
DB370407   .l 2581 to 3134 555 to 1       555/555
(100 %)
12 diff
(97.9 %id)
DB323736   .l 2613 to 3134 523 to 1       523/523
(100 %)
3 diff
(99.5 %id)
AA132531 colon, tumor .l 2684 to 3135 453 to 1   tiling clone,   453/453
(100 %)
2 diff
(99.6 %id)
R70915 placenta .l 2703 to 3045 352 to 1       352/364
(96 %)
22 diff
(94.0 %id)
DA708641   .m 1 to 547 2 to 553 exact capped   552/553
(99 %)
10 diff
(98.2 %id)
DA708657   .m 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
AL583521 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .n 1 to 809 2 to 800 N65Y tiling clone,   800/800
(100 %)
13 diff
(98.4 %id)
DB134270 thymus .o 1 to 534 7 to 540 exact tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
DB272526 uterus .o 1 to 558 7 to 564 exact tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
DA497861 brain .p 1 to 792 2 to 580   tiling clone, capped Suspected internal deletion 579/579
(100 %)
4 diff
(99.4 %id)
NM_001105550.1   .q 1 to 2824 1 to 2824 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2824/2824
(100 %)
0 diff
(100 %id)
BP243198 Liver .q 37 to 613 1 to 577 exact tiling clone,   577/577
(100 %)
2 diff
(99.7 %id)
DA147772 amygdala .q 45 to 578 2 to 535 exact capped   534/534
(100 %)
0 diff
(100 %id)
DA151844 amygdala .q 45 to 622 2 to 579 exact tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
DA868327 Prostate .q 46 to 611 2 to 568 exact capped   567/567
(100 %)
2 diff
(99.7 %id)
BM806423 melanotic melanoma, skin .q 60 to 611 1 to 556 exact     556/960
(57 %)
16 diff
(98.4 %id)
DW451571 Liver .r 1 to 315 56 to 370 R33K tiling clone,   316/376
(84 %)
10 diff
(97.4 %id)
BQ718562 sympathetic trunk .r 1 to 905 33 to 941 F3S R33K tiling clone,   912/942
(96 %)
46 diff
(95.2 %id)
CV363102 breast_normal .r 686 to 1075 412 to 23   tiling clone, Submitted on the opposite strand 390/415
(93 %)
0 diff
(100 %id)
CV363099 breast_normal .r 697 to 1026 349 to 18     Submitted on the opposite strand 332/349
(95 %)
0 diff
(100 %id)
DA701045   .s 1 to 521 2 to 523 R27K L35S tiling clone, capped   522/522
(100 %)
4 diff
(99.3 %id)
DB156129 thymus .t 1 to 592 2 to 593 R27K tiling clone, capped   592/592
(100 %)
2 diff
(99.7 %id)
DR001735 fetal brain .u -8 to 651 1 to 657 R27K tiling clone,   657/661
(99 %)
12 diff
(98.2 %id)
DA231238 brain .u 29 to 572 2 to 547 L19S P20S Q21S C23M L24P ... tiling clone, capped   546/546
(100 %)
13 diff
(97.7 %id)
BX491486   .u 81 to 666 46 to 633 E4* tiling clone,   588/633
(92 %)
10 diff
(98.5 %id)
DA125855 cerebellum .va 1 to 595 2 to 596 exact tiling clone, capped   595/595
(100 %)
1 diff
(99.9 %id)
DA108939 cerebellum .vb 1 to 577 2 to 579 L24X T25D R27Q D28G V29C ... tiling clone, capped   578/578
(100 %)
1 diff
(99.9 %id)
DA106367 cerebellum .vc 1 to 534 4 to 537 exact capped   536/536
(100 %)
0 diff
(100 %id)
DA109862 cerebellum .vc 1 to 558 4 to 561 exact tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
NM_001105551.1   .vd 1 to 2850 1 to 2850 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2850/2850
(100 %)
0 diff
(100 %id)
DB252431 uterus .vd 28 to 587 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
DA422125 cervix .vd 30 to 602 2 to 572 exact capped   571/571
(100 %)
1 diff
(99.9 %id)
DA623855 Kidney .vd 30 to 583 2 to 555 exact capped   554/554
(100 %)
0 diff
(100 %id)
DA889194   .vd 30 to 587 2 to 559 exact capped   558/558
(100 %)
0 diff
(100 %id)
DB059429 testis .vd 35 to 542 2 to 509 exact capped   508/508
(100 %)
6 diff
(98.9 %id)
DA566471 heart .vd 36 to 603 2 to 570 exact capped   569/569
(100 %)
2 diff
(99.7 %id)
DA962645 stomach .vd 38 to 546 2 to 510 K23X capped   509/509
(100 %)
5 diff
(99.1 %id)
DA382052 thalamus .vd 43 to 615 2 to 574 exact capped   573/573
(100 %)
0 diff
(100 %id)
DA384065 thalamus .vd 43 to 595 2 to 554 exact capped   553/553
(100 %)
0 diff
(100 %id)
DA940690 Spleen .vd 57 to 627 2 to 572 exact capped   571/571
(100 %)
0 diff
(100 %id)
DA377904 thalamus .vd 202 to 834 2 to 634   tiling clone, capped   633/633
(100 %)
1 diff
(99.9 %id)
BE156323 head_neck .vd 301 to 635 2 to 335       334/335
(99 %)
8 diff
(97.7 %id)
CN426876 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vd 303 to 948 1 to 646       646/646
(100 %)
3 diff
(99.6 %id)
BC063032 Lymph, lymphoma .vd 377 to 2839 15 to 2477   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2463/2463
(100 %)
6 diff
(99.8 %id)
DA341245 substantia nigra .ve 1 to 563 2 to 564 exact tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
DA011334 adrenal gland .vf 1 to 548 2 to 544 exact tiling clone, capped   543/543
(100 %)
3 diff
(99.5 %id)
DB214236 trachea .vg 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
23 diff
(95.9 %id)
CN417586 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vh 1 to 735 1 to 736 exact tiling clone,   736/736
(100 %)
8 diff
(99.0 %id)
DA183557 amygdala .vh 6 to 491 2 to 487 exact tiling clone, capped   486/486
(100 %)
1 diff
(99.8 %id)
DA231161 brain .vh 32 to 583 2 to 553 E55K capped   552/552
(100 %)
5 diff
(99.1 %id)
DA237788 brain .vh 32 to 606 2 to 576 E55K capped   575/575
(100 %)
9 diff
(98.5 %id)
DA324188 hippocampus .vh 32 to 555 2 to 528 exact capped   527/527
(100 %)
6 diff
(98.9 %id)
DB276967 uterus .vh 32 to 490 2 to 460 E55K capped   459/459
(100 %)
5 diff
(99.0 %id)
DB080772 testis .vh 33 to 571 12 to 550 exact capped   539/549
(98 %)
6 diff
(99.0 %id)
DB218242 trachea .vh 42 to 579 2 to 540 exact capped   539/539
(100 %)
5 diff
(99.1 %id)
DA297086 hippocampus .vh 48 to 603 2 to 557 E55K capped   556/556
(100 %)
7 diff
(98.8 %id)
CN278387 embryonic stem cells, DMSO-treated H9 cellline .vh 52 to 369 1 to 318       318/318
(100 %)
4 diff
(98.8 %id)
BU949854 Pancreas, Purified pancreatic islet .vh 303 to 529 6 to 232   fully sequenced,   227/232
(97 %)
5 diff
(97.9 %id)
BU626289 Bone, Subchondral Bone .vh 323 to 955 651 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 633/633
(100 %)
20 diff
(96.9 %id)
BU949570 Pancreas, Purified pancreatic islet .vh 499 to 955 457 to 1   tiling clone, fully sequenced,   457/457
(100 %)
3 diff
(99.4 %id)
DT216882 brain .vi 1 to 703 2 to 703 R27K V29A tiling clone,   703/703
(100 %)
5 diff
(99.3 %id)
DA100765 cerebellum .vj 1 to 574 2 to 576 exact tiling clone, capped   575/575
(100 %)
2 diff
(99.7 %id)
DA589517 lung .vk 1 to 571 3 to 574 T25D R27Q D28G V29C A30G ... tiling clone, capped   573/573
(100 %)
3 diff
(99.5 %id)
DA434207 tongue, tumor tissue .vk 1 to 529 2 to 531 R27K tiling clone, capped   530/530
(100 %)
2 diff
(99.7 %id)
AB209516 brain Gene ZNF83, variant not shown         Suspected internal deletion, this clone was ignored    
AV705050 adrenal gland Gene ZNF83, variant not shown         Suspected internal deletion, this clone was ignored    
AV702929 adrenal gland Gene ZNF83, variant not shown         Suspected internal deletion, this clone was ignored    
AV708374 adrenal gland Gene ZNF83, variant not shown         Suspected internal deletion, this clone was ignored    
DA108951 cerebellum Gene ZNF83, variant not shown       capped This clone was ignored    
DA232820 brain Gene ZNF83, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA234557 brain Gene ZNF83, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA243524 brain Gene ZNF83, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB311117 thalamus Gene ZNF83, variant not shown         This clone was ignored    
DA375319 thalamus Gene ZNF83, variant not shown       capped This clone was ignored    
DA406119 thalamus Gene ZNF83, variant not shown       capped Suspected internal deletion, this clone was ignored    
F04001 brain, total brain Gene ZNF83, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
F07748 brain, total brain Gene ZNF83, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
DA601801   Gene ZNF83, variant not shown       capped This clone was ignored    
AA960961 pooled Gene ZNF83, variant not shown         Submitted on the opposite strand    
AW592584 pooled Gene ZNF83, variant not shown         Submitted on the opposite strand    
BC013321 Prostate Gene ZNF83, variant not shown       available from MGC, AAA This clone was ignored    
BF674302 Prostate Gene ZNF83, variant not shown       available from MGC, This clone was ignored    
DA762987 tongue Gene ZNF83, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
AU155589 placenta Gene ZNF83, variant not shown         This clone was ignored    
DA828039 placenta Gene ZNF83, variant not shown       capped This clone was ignored    
DB379725 placenta Gene ZNF83, variant not shown         Suspected internal deletion, this clone was ignored    
DA833141 placenta Gene ZNF83, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA863416 placenta Gene ZNF83, variant not shown       capped This clone was ignored    
DN994623 brain, whole brain Gene ZNF83, variant not shown         This clone was ignored    
BQ013399 placenta Gene ZNF83, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI